In this three minute clip, Fergus Walsh reports on a trial being conducted at Guy’s and St Thomas’ NHS Foundation Trust (London). The research, led by Prof Mark Peakman, is using a combination of protein fragments (MultiPepT1De) to try and trigger a “protective” immune response, rather than the inappropriate antibody production against islet cells that underlies Type 1 diabetes.
This link includes a video by Prof Peakman introducing the biochemistry of Type I diabetes and the basis of their research (5 mins). See also this article by Peakman on the principles behind the new approach.
The same news item is currently also available on the BBC news website.